Skip To Main Content
Laura Bowles Zeiser on Muck Rack

Laura Bowles Zeiser

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Laura Bowles

Contact Laura Bowles, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease

|
By Evangelos Tsipotis, Ankith Maremanda, Laura Bowles Zeiser, Caoilfhionn M Connolly
| MDPI
1. Introduction Initial findings have demonstrated that the majority of patients with inflammatory bowel disease (IBD), including those with Ulcerative Colitis (UC) and/or Crohn’s Disease (CD), develop antibodies that persist for at least 6 months following a two-dose series of SARS-CoV-2 mRNA vaccines [1,2,3].
Open in Who Shared Issue with article?
See all 1 articles